Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
December 21, 2021
SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation
Shi Yu, Xu Zheng, Bingjie Zhou, et al.
Viruses
|
August 28, 2021
Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines
Yong Yang, Jinkai Zang, Shiqi Xu, et al.
The Journal of General Virology
|
April 9, 2010
Characterization of hepatitis C virus pseudoparticles by cryo-transmission electron microscopy using functionalized magnetic nanobeads
Pierre Bonnafous, Marie Perrault, Olivier Le Bihan, et al.
The Journal of Biological Chemistry
|
August 1, 2008
Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity
Emmanuel Fenouillet, Dimitri Lavillette, Silvia Loureiro, et al.
Frontiers in Immunology
|
July 18, 2022
Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
Jinkai Zang, Yannan Yin, Shiqi Xu, et al.
Virology
|
February 6, 2019
Comparative study of chikungunya Virus-Like Particles and Pseudotyped-Particles used for serological detection of specific immunoglobulin M
Gérald Theillet, Jérôme Martinez, Christophe Steinbrugger, et al.
The Journal of Biological Chemistry
|
September 1, 2007
The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus
Marlène Dreux, Bertrand Boson, Sylvie Ricard-Blum, et al.
Journal of Virology
|
June 1, 2007
Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus
Dimitri Lavillette, Eve-Isabelle Pécheur, Peggy Donot, et al.
Biochemistry
|
April 26, 2007
Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol
Eve-Isabelle Pécheur, Dimitri Lavillette, Fanny Alcaras, et al.
Journal of Virology
|
June 16, 2005
An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies
Birke Bartosch, Géraldine Verney, Marlène Dreux, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
Proceedings of the National Academy of Sciences of the United States of America
|
December 21, 2021
SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation
Shi Yu, Xu Zheng, Bingjie Zhou, et al.
Viruses
|
August 28, 2021
Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines
Yong Yang, Jinkai Zang, Shiqi Xu, et al.
The Journal of General Virology
|
April 9, 2010
Characterization of hepatitis C virus pseudoparticles by cryo-transmission electron microscopy using functionalized magnetic nanobeads
Pierre Bonnafous, Marie Perrault, Olivier Le Bihan, et al.
The Journal of Biological Chemistry
|
August 1, 2008
Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity
Emmanuel Fenouillet, Dimitri Lavillette, Silvia Loureiro, et al.
Frontiers in Immunology
|
July 18, 2022
Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
Jinkai Zang, Yannan Yin, Shiqi Xu, et al.
Virology
|
February 6, 2019
Comparative study of chikungunya Virus-Like Particles and Pseudotyped-Particles used for serological detection of specific immunoglobulin M
Gérald Theillet, Jérôme Martinez, Christophe Steinbrugger, et al.
The Journal of Biological Chemistry
|
September 1, 2007
The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus
Marlène Dreux, Bertrand Boson, Sylvie Ricard-Blum, et al.
Journal of Virology
|
June 1, 2007
Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus
Dimitri Lavillette, Eve-Isabelle Pécheur, Peggy Donot, et al.
Biochemistry
|
April 26, 2007
Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol
Eve-Isabelle Pécheur, Dimitri Lavillette, Fanny Alcaras, et al.
Journal of Virology
|
June 16, 2005
An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies
Birke Bartosch, Géraldine Verney, Marlène Dreux, et al.
Page
of 8